
What happened
Nikkei Crosstrend launched a 10-part series calling 2026 the first year of AI agents, with cases including KOSÉ hitting a 100% customer-support connection rate.
Why it matters
The series frames AI not as an efficiency tool but as a management factor that reshapes how work is structured, dividing companies into winners and losers.
Summaries like this, every morning.
The series is organized by function rather than by technology, and that choice carries the argument. Each installment pairs a user company with the operational problem that function faces — KOSÉ pushing customer-support connection to 100%, Mitsubishi Corporation using accumulated legal data to spot blind spots in contracts and investments, Fujitsu integrating financial data to read performance ahead of the curve. Read together, they suggest AI adoption is advancing unevenly across departments rather than arriving as a single company-wide switch.
The framing of 2026 as the first year of AI agents rests on a distinction the series makes early: agents understand a task's goal and act on their own, which is a different proposition from automating a defined step. That is why the series ties competitiveness to redesign of management and organization rather than to tool selection, and warns that companies unable to wield this strategic asset will be filtered out.
The series also tracks the vendor side, noting that SaaS providers specialized by business function are moving to capture markets with AI, and that products for procurement automation are expected to appear in Japan from the second half of 2026. Shionogi is cited among the advanced companies already examining AI use in procurement.
Pick your industry and the AI tools you use, and get news related to your work every day.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
S&P Global reports Q3 on Oct

Tempus AI expanded its drug development collaborations with Bristol Myers Squibb and Pathos AI

Vertiv and NVIDIA presented at GTC on how they can halve AI factory deployment time

Danaher (DHR) received FDA clearance for AI-powered atrial fibrillation detection

CVS Health appointed Jack Hanlon, who previously held senior data and analytics roles at Meta and Reddit, as s…

T-Mobile US completed what Nvidia described as the first AI-RAN call on a live commercial network, unveiled at…
